Royal Bank of Canada’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1K Sell
151
-706
-82% -$4.36K ﹤0.01% 6881
2025
Q4
$6K Buy
857
+312
+57% +$2.34K ﹤0.01% 6640
2025
Q3
$5K Sell
545
-1,475
-73% -$11K ﹤0.01% 6698
2025
Q2
$15K Sell
2,020
-117
-5% -$787 ﹤0.01% 6357
2025
Q1
$15K Sell
2,137
-1,982
-48% -$18.7K ﹤0.01% 6013
2024
Q4
$37K Buy
4,119
+1,438
+54% +$13.4K ﹤0.01% 5838
2024
Q3
$25K Buy
2,681
+72
+3% +$756 ﹤0.01% 6024
2024
Q2
$21K Sell
2,609
-40,935
-94% -$317K ﹤0.01% 6055
2024
Q1
$352K Buy
43,544
+35,177
+420% +$249K ﹤0.01% 4218
2023
Q4
$46K Buy
8,367
+3,893
+87% +$20.6K ﹤0.01% 6033
2023
Q3
$23K Buy
4,474
+1,380
+45% +$9.81K ﹤0.01% 6128
2023
Q2
$36K Buy
3,094
+1,044
+51% +$12.3K ﹤0.01% 5929
2023
Q1
$25K Sell
2,050
-2,331
-53% -$44.6K ﹤0.01% 5942
2022
Q4
$86K Buy
4,381
+3,581
+448% +$77.1K ﹤0.01% 5564
2022
Q3
$20K Buy
800
+247
+45% +$6.82K ﹤0.01% 6138
2022
Q2
$14K Sell
553
-1,088
-66% -$28.9K ﹤0.01% 6244
2022
Q1
$53K Sell
1,641
-1,912
-54% -$60.1K ﹤0.01% 6052
2021
Q4
$120K Sell
3,553
-573
-14% -$20.8K ﹤0.01% 5793
2021
Q3
$177K Buy
4,126
+622
+18% +$38.2K ﹤0.01% 5277
2021
Q2
$228K Buy
3,504
+695
+25% +$44K ﹤0.01% 4961
2021
Q1
$148K Sell
2,809
-6,415
-70% -$320K ﹤0.01% 5159
2020
Q4
$412K Sell
9,224
-292
-3% -$10.1K ﹤0.01% 4299
2020
Q3
$276K Sell
9,516
-16,981
-64% -$533K ﹤0.01% 4313
2020
Q2
$941K Sell
26,497
-203
-0.8% -$8.55K ﹤0.01% 3228
2020
Q1
$1.38M Buy
26,700
+11,589
+77% +$557K ﹤0.01% 2782
2019
Q4
$1.03M Buy
15,111
+11,365
+303% +$713K ﹤0.01% 3420
2019
Q3
$179K Sell
3,746
-30,677
-89% -$1.6M ﹤0.01% 4512
2019
Q2
$2.3M Sell
34,423
-158,475
-82% -$12.1M ﹤0.01% 2639
2019
Q1
$18.4M Buy
192,898
+45,003
+30% +$5.61M 0.01% 1124
2018
Q4
$18.4M Buy
147,895
+60,644
+70% +$9.99M 0.01% 1048
2018
Q3
$21.3M Sell
87,251
-31,392
-26% -$7.26M 0.01% 1092
2018
Q2
$22.1M Sell
118,643
-123,429
-51% -$20.5M 0.01% 1014
2018
Q1
$29.7M Sell
242,072
-38,374
-14% -$4.68M 0.01% 846
2017
Q4
$33.4M Buy
280,446
+3,460
+1% +$381K 0.01% 821
2017
Q3
$26.3M Sell
276,986
-34,993
-11% -$3.37M 0.01% 930
2017
Q2
$29.8M Buy
311,979
+1,530
+0.5% +$131K 0.02% 806
2017
Q1
$24.1M Buy
310,449
+13,286
+4% +$921K 0.01% 912
2016
Q4
$20M Buy
297,163
+37,351
+14% +$2.3M 0.01% 1074
2016
Q3
$15.6M Buy
259,812
+1,871
+0.7% +$104K 0.01% 1164
2016
Q2
$12.9M Buy
257,941
+233,283
+946% +$11.1M 0.01% 1272
2016
Q1
$1.11M Buy
24,658
+3,755
+18% +$134K ﹤0.01% 2965
2015
Q4
$838K Buy
20,903
+18,055
+634% +$763K ﹤0.01% 3271
2015
Q3
$138K Buy
2,848
+11
+0.4% +$522 ﹤0.01% 4570
2015
Q2
$126K Buy
2,837
+1,703
+150% +$65.3K ﹤0.01% 4693
2015
Q1
$36K Sell
1,134
-66
-6% -$2.13K ﹤0.01% 5116
2014
Q4
$37K Buy
1,200
+200
+20% +$4.85K ﹤0.01% 5178
2014
Q3
$21K Hold
1,000
﹤0.01% 5272
2014
Q2
$23K Buy
+1,000
New +$16.6K ﹤0.01% 5149

Other funds holding INGN

Royal Bank of Canada's INGN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Inogen (INGN) stake by 82% in Q1 2026, selling an estimated $4.36K and leaving 151 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6881.

Royal Bank of Canada first reported a position in INGN in Q2 2014 and has held it in 48 quarters since. The position peaked at $33.4M in Q4 2017. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Royal Bank of Canada held 151 shares of Inogen worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 706 Inogen shares in Q1 2026, an estimated $4.36K.
  • Inogen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6881 holding.
  • Royal Bank of Canada first reported a position in Inogen in Q2 2014 and has held it in 48 quarters since.
  • Royal Bank of Canada's Inogen position peaked at $33.4M in Q4 2017.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.